메뉴 건너뛰기




Volumn 3, Issue 3, 2002, Pages 249-255

Pharmacoeconomics of drug therapy for atopic dermatitis

Author keywords

Children; Cost effectiveness; Eczema; Family stress; Immunomodulators; Indirect costs

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; AZATHIOPRINE; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN A; EMOLLIENT AGENT; GAMMA INTERFERON; GLUCOCORTICOID; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; IMMUNOGLOBULIN; LACTAM DERIVATIVE; MACROLACTAM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIMECROLIMUS; PREDNISONE; PROMETHAZINE; TACROLIMUS; UNCLASSIFIED DRUG;

EID: 0036192755     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.3.249     Document Type: Article
Times cited : (20)

References (43)
  • 4
    • 0003574770 scopus 로고
    • Essential aspects of atopic dermatitis
    • Springer-Verlag (Berlin)
    • (1989) , pp. 1
    • Rajka, G.1
  • 8
    • 0035937863 scopus 로고    scopus 로고
    • The burden of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema in children and adolescents in six New Zealand centres: ISAAC Phase One
    • (2001) NZ Med. J. , vol.114 , pp. 114-120
    • Asher, M.I.1    Barry, D.2    Clayton, T.3
  • 31
  • 33
    • 0034044350 scopus 로고    scopus 로고
    • Pharmacoeconomics of drug therapy for rheumatoid arthritis
    • (2000) Rheumatology , vol.39 , Issue.SUPPL. 1 , pp. 43-47
    • Tugwell, P.1
  • 36
    • 0027510240 scopus 로고
    • Severity scoring of atopic dermatitis: The SCORAD index
    • European Task Force on Atopic Dermatitis
    • (1993) Dermatology , vol.186 , pp. 23-31


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.